Scolaris Content Display Scolaris Content Display

Ecografía sistemática en la última etapa del embarazo (después de 24 semanas de gestación)

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Alesund 1999 {published and unpublished data}

Eik‐Nes SH. Effects of routine two‐stage ultrasound screening in pregnancy: the Alesund randomised controlled trial revisited. Personal communication1984.
Eik‐Nes SH, Okland O, Aure JC, Ulstein M. Ultrasound screening in pregnancy: a randomised controlled trial [letter]. Lancet 1984;1:1347.
Eik‐Nes SH, Salvesen KA, Okland O, Vatten LJ. Routine ultrasound fetal examination in pregnancy: the Alesund randomised controlled trial. Ultrasound in Obstetrics and Gynecology 2000;15(6):473‐8.

Belanger 1996 {published data only}

Belanger K, Hobbins JC, Muller JP, Howard S. Neurological testing in ultrasound exposed infants. American Journal of Obstetrics and Gynecology 1996;174(1 Pt 2):413.

Belfast 2003 {published data only}

McKenna D, Tharmaratnam S, Harper A, Dornan J. A randomised controlled trial using serial directed real time ultrasound to identify the at risk fetus in a low risk population. XVI FIGO World Congress of Obstetrics & Gynecology. Book 1; 2000 Sept 3‐8; Washington DC, USA. 2000:25.
McKenna D, Tharmaratnam S, Harper A, Dornan J. A randomised controlled trial using serial directed real time ultrasound to identify the at‐risk fetus in a low risk population [abstract]. Prenatal and Neonatal Medicine 2000;5(Suppl 2):151.
McKenna D, Tharmaratnam S, Mahsud S, Bailie C, Harper A, Dornan J. A randomized trial using ultrasound to identify the high‐risk fetus in a low‐risk population. Obstetrics & Gynecology 2003;101(4):626‐32.

Ellwood 1997 {published data only}

Ellwood D, Peek M, Curren J. Predicting adverse pregnancy outcomes with ultrasound. A randomised controlled trial. Personal communication1997.

Glasgow 1984 {published data only}

Neilson JP, Munjanja SP, Whitfield CR. Screening for small for dates fetuses: a controlled trial. BMJ 1984;289:1179‐82.

New Zealand 1993 {published data only}

Duff G. A randomised controlled trial in a hospital population of ultrasound measurement screening for the small for dates baby. Proceedings of 2nd International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1993 Sept 7‐10; Hong Kong. 1993:90.
Duff GB. A randomised controlled trial in a hospital population of ultrasound measurement screening for the small for dates baby. Australian and New Zealand Journal of Obstetrics and Gynaecology 1993;33(4):374‐8.

Norway 1992 {published data only}

Salvesen KA. Routine ultrasonography in utero and development in childhood ‐ a randomized controlled follow‐up study. Acta Obstetricia et Gynecologica Scandinavica1995; Vol. 74:166‐7.
Salvesen KA. Ultrasound and left‐handedness: a sinister association?. Ultrasound in Obstetrics & Gynecology 2002;19(3):217‐21.
Salvesen KA, Bakketeig LS, Eik‐nes SH, Undheim JO, Okland O. Routine ultrasonography in utero and school performance at age 8‐9 years. Lancet 1992;339(8785):85‐9.
Salvesen KA, Eik‐Nes SH. Ultrasound during pregnancy and birthweight, childhood malignancies and neurological development. Ultrasound in Medicine & Biology 1999;25(7):1025‐31.
Salvesen KA, Eik‐Nes SH. Ultrasound during pregnancy and subsequent childhood non‐right handedness: a meta‐analysis. Ultrasound in Obstetrics & Gynecology 1999;13(4):241‐6.
Salvesen KA, Jacobsen G, Vatten LJ, Eik‐Nes SH, Bakketeig LS. Routine ultrasonography in utero and subsequent growth during childhood. Ultrasound in Obstetrics & Gynecology 1993;3:6‐10.
Salvesen KA, Vatten LJ, Eik‐Nes SH, Hugdahl K, Bakketeig LS. Routine ultrasonography in utero and subsequent handedness and neurological development. BMJ 1993;307(6897):159‐64.
Salvesen KA, Vatten LJ, Jacobsen G, Eik‐Nes SH, Okland O, Molne K, et al. Routine ultrasonography in utero and subsequent vision and hearing at primary school age. Ultrasound in Obstetrics & Gynecology 1992;2:243‐7.

Perth 1993 {published and unpublished data}

Evans S, Newnham J, MacDonald W, Hall C. Characterisation of the possible effect on birthweight following frequent prenatal ultrasound examinations. Early Human Development 1996;45(3):203‐14.
Forward H, Yazar S, Hewitt AW, Khan J, Mountain JM, Pesudovs K, et al. Multiple prenatal ultrasound scans and ocular development: 20‐year follow‐up of a randomised, controlled trial. Ultrasound in Obstetrics & Gynecology 2014;44:166‐70.
Harding K, Evans S, Newnham J. Screening for the small fetus: a study of the relative efficacies of ultrasound biometry and symphysiofundal height. Australian and New Zealand Journal of Obstetrics and Gynaecology 1995;35:160‐4.
Newnham J, MacDonald W, Gurrin L, Evans S, Landau L, Stanley F. The effect of frequent prenatal ultrasound on birthweight: follow up at one year of age. Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996 March 24‐27; Adelaide, Australia. 1996:A26.
Newnham JP, Doherty DA, Kendall GE, Zubrick SR, Landau LL, Stanley FJ. Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age: follow‐up of a randomised controlled trial. Lancet 2004;364:2038‐44.
Newnham JP, Evans SF, Michael CA, Stanley FJ, Landau LI. Effects of frequent ultrasound during pregnancy: a randomised controlled trial. Lancet 1993;342:887‐91.
Stoch YK, Williams CJ, Granich J, Hunt AM, Landau LI, Newnham JP, et al. Are prenatal ultrasound scans associated with the autism phenotype? Follow‐up of a randomised controlled trial. Journal of Autism & Developmental Disorders 2012;42(12):2693‐701.

Peterborough 1987 {published data only}

Proud J, Grant AM. Third trimester placental grading by ultrasonography as a test of fetal wellbeing. BMJ 1987;294:1641‐4.

RADIUS 1993 {published data only}

Crane JP, LeFevre ML, Winborn RC, Evans JK, Ewigman BG, Bain RP, et al. A randomized trial of prenatal ultrasonographic screening: Impact on the detection, management and outcome of anomalous fetuses. American Journal of Obstetrics and Gynecology 1994;171:392‐9.
Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D, et al. Effect of prenatal ultrasound screening on perinatal outcome. New England Journal of Medicine 1993;329:821‐7.
LeFevre ML, Bain RP, Ewigman BG, Frigoletto FD, Crane JP, McNellis D, et al. A randomised trial of prenatal ultrasonographic screening: impact on maternal management and outcome. American Journal of Obstetrics and Gynecology 1993;169:483‐9.

Skrastad 2013 {published data only}

Skrastad RB, Eik‐Nes SH, Sviggum O, Johansen OJ, Salvesen KA, Romundstad PR, et al. A randomized controlled trial of third‐trimester routine ultrasound in a non‐selected population. Acta Obstetricia et Gynecologica Scandinavica 2013;92(12):1353‐60.

Trondheim 1984 {published data only}

Bakketeig LS, Jacobsen G, Brodtkorb CJ, Eriksen BC, Eik‐Nes SH, Ulstein MK, et al. Randomised controlled trial of ultrasonographic screening in pregnancy. Lancet 1984;2:207‐10.

Wladimiroff 1980 {published data only}

Wladimiroff JW, Laar J. Ultrasonic measurement of fetal body size. A randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica 1980;59:177‐9.

References to studies excluded from this review

Arzola 2013 {published data only}

Arzola C. Quantitative ultrasound assessment of gastric volume in pregnant women at term. ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 5 February 2014]2013.

Hendrix 2000 {published data only}

Hendrix NW, Grady CS, Chauhan SP. Clinical vs sonographic estimate of birth weight in term parturients. Journal of Reproductive Medicine 2000;45(4):317‐22.

Morrison 1992 {published data only}

Morrison JC. Is shoulder dystocia predictable by a ponderal index obtained ultrasonographically?. Personal communication1992.

Ong 2001 {published data only}

Ong S. Third trimester placental grading by ultrasound and its impact on perinatal mortality. National Research Register2001.

Owen 1994 {published data only}

Owen P, Donnet L, Ogston S, Christie A, Patel N, Howie P. A study of fetal growth velocity. British Journal of Obstetrics and Gynaecology 1994;101:270.

Secher 1986 {published data only}

Secher NJ, Hansen PK, Lenstrup C, Eriksen PS. Controlled trial of ultrasound screening for light for gestational age (LGA) infants in late pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 1986;23:307‐13.

Secher 1987 {published data only}

Secher NJ, Hansen PK, Lenstrup C, Eriksen PS, Morsing G. A randomized study of fetal abdominal diameter and fetal weight estimation for detection of light‐for‐gestation infants in low‐risk pregnancies. British Journal of Obstetrics and Gynaecology 1987;94:105‐9.

McClure 2014 {published data only}

McClure E. A cluster‐randomized trial of ultrasound use to improve pregnancy outcomes in low income country settings. ClinicalTrials.gov (http://clinicaltrials.gov) [accessed 14 January 2014]2014.
McClure EM, Nathan RO, Saleem S, Esamai F, Garces A, Chomba E, et al. First look: a cluster‐randomized trial of ultrasound to improve pregnancy outcomes in low income country settings. BMC Pregnancy and Childbirth 2014;14(1):73.

Verspyck 2012 {published data only}

Verspyck E. Routine ultrasound screening in the third trimester (RECRET). http://clinicaltrials.gov/show/NCT01594463(accessed July 2012).

Abramowicz 2007

Abramowicz JS, Sheiner E. In utero imaging of the placenta: Importance for diseases of pregnancy. Placenta 2007;21(Suppl A):S14‐S22.

ACOG 2004

ACOG Committee on Ethics. ACOG Committee Opinion. Number 297, August 2004. Nonmedical use of obstetric ultrasonography. Obstetrics & Gynecology 2004;104(2):423‐4.

Alfirevic 2015

Alfirevic Z, Stampalija T, Medley N. Fetal and umbilical Doppler ultrasound in normal pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 4. [DOI: 10.1002/14651858.CD001450.pub4]

Altman 1989

Altman DG, Hytten F. Assessment of fetal size and fetal growth. In: Chalmers I, Enkin M, Keirse MJNC editor(s). Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989:411‐8.

Barker 1993

Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993;341:938‐41.

Brace 1989

Brace RA, Wolf EJ. Characterisation of normal gestational changes in amniotic fluid volume. American Journal of Obstetrics and Gynecology 1989;161:382‐8.

Chitty 1995

Chitty LS. Ultrasound screening for fetal abnormalities. Prenatal Diagnosis 1995;15:1241‐57.

EFSUMB 1995

Societies for Ultrasound in Medicine, Biology. European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Watchdog Committee, 1994 Clinical Safety Statement (1995). European Journal of Ultrasound 1995;2:77.

Garcia 2002

Garcia J, Bricker L, Henderson J, Martin M, Mugford M, Nielson J, et al. Women's views of pregnancy ultrasound: a systematic review. Birth 2002;29(4):225‐50.

Gates 2004

Gates S, Brocklehurst P. How should randomised trials including multiple pregnancies be analysed?. BJOG: an international journal of obstetrics and gynaecology 2004;111:213‐9.

Gonen 1996

Gonen R, Spiegal D, Abend M. Is macrosomia predictable, and are shoulder dystocia and birth trauma preventable?. Obstetrics & Gynecology 1996;88(4):526‐9.

GRADE 2014 [Computer program]

McMaster University. GRADEpro. [Computer program on www.gradepro.org]. Version 2014. McMaster University, 2014.

Grannum 1979

Grannum PA, Berkowitz RL, Hobbins JC. The ultrasonic changes in the maturing placenta and their relation to fetal pulmonary maturity. American Journal of Obstetrics and Gynecology 1979;133:915‐22.

Harding 1995

Harding K, Evans S, Newnham J. Screening for the small fetus: a study of the relative efficacies of ultrasound biometry and symphysiofundal height. Australian and New Zealand Journal of Obstetrics and Gynaecology 1995;35:160‐4.

Henderson 2002

Henderson J, Bricker L, Roberts T, Mugford M, Garcia J, Neilson J. British National Health Service's and women's costs of antenatal ultrasound screening and follow‐up tests. Ultrasound in Obstetrics & Gynecology 2002;20(2):154‐62.

Higgins 2011

Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Holmes 1996

Holmes RP, Soothill PW. Intra‐uterine growth retardation. Current Opinion in Obstetrics and Gynecology 1996;8:148‐54.

Leeson 1997

Leeson S, Aziz N. Customised fetal growth assessment. British Journal of Obstetrics and Gynaecology 1997;104:648‐51.

Lindqvist 2005

Lindqvist P G, Molin J. Does antenatal identification of small‐for‐gestational age fetuses significantly improve their outcome?. Ultrasound in Obstetrics & Gynecology 2005;25(3):258‐64.

Lurie 1995

Lurie S, Yalel Y, Hagay ZJ. The evaluation of accelerated fetal growth. Current Opinion in Obstetrics and Gynecology 1995;7(6):477‐81.

Neilson 1989

Neilson JP, Grant A. Ultrasound in pregnancy. In: Chalmers I, Enkin M, Keirse MJNC editor(s). Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989:419‐39.

Newnham 1996

Newnham J, MacDonald W, Gurrin L, Evans S, Landau L, Stanley F. The effect of frequent prenatal ultrasound on birthweight: follow up at one year of age. Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996 March 24‐27; Adelaide, Australia. 1996:A26.

Newnham 2004

Newnham JP, Doherty DA, Kendall GE, Zubrick SR, Landau LL, Stanley FJ. Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age: follow‐up of a randomised controlled trial. Lancet 2004;364:2038‐44.

Nwosu 1993

Nwosu EC, Walkinshaw S, Chia P, Manasse PR, Atlay RD. Undiagnosed breech. British Journal of Obstetrics and Gynaecology 1993;100(6):531‐5.

RCOG 1997

Royal College of Obstetricians and Gynaecologists. Report of RCOG Working Party on Ultrasound Screening for Fetal Abnormalities. London: RCOG, 1997.

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Rizos 1979

Rizos N, Miskin M, Benzie RJ, Ford JA. Natural history of placenta praevia ascertained by diagnostic ultrasound. American Journal of Obstetrics and Gynecology 1979;133:287‐91.

Schunemann 2009

Schunemann HJ. GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice [GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2009;103(6):391‐400. [PUBMED: 19839216]

Sheiner 2007

Sheiner E, Shoham‐Vardi I, Abramowicz JS. What do clinical users know regarding safety of ultrasound during pregnancy?. Journal of Ultrasound in Medicine 2007;26(3):319‐25; quiz 326‐7.

Stoch 2012

Stoch Y, Williams C, Granich J, Hunt A, Landau L, Newnham J, et al. Are prenatal ultrasound scans associated with the autism phenotype? Follow‐up of a randomised controlled trial. Journal of Autism and Developmental Disorders 2012;42:2693‐701.

Villar 2014

Villar J, Papageorghiou AT, Pang R, Ohuma EO, Ismail LC, Barros FC, et al for the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH‐21st). The likeness of fetal growth and newborn size across non‐isolated populations in the INTERGROWTH‐21st Project: the Fetal Growth Longitudinal Study and Newborn Cross‐Sectional Study. Lancet Diabetes and Endocrinology 2014;2(10):781‐92.

Weeks 1995

Weeks JW, Pitman T, Spinnato JA. Fetal macrosomia : does antenatal prediction affect delivery route and birth outcome? [Weeks JW1, Pitman T, Spinnato JA 2nd.]. American Journal of Obstetrics and Gynecology 1995;173(4):1215‐9.

Whitworth 2010

Whitworth M, Bricker L, Neilson JP, Dowswell T. Ultrasound for fetal assessment in early pregnancy. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD007058.pub2]

References to other published versions of this review

Bricker 2000

Bricker L, Neilson JP. Routine ultrasound in late pregnancy (after 24 weeks gestation. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD001451]

Bricker 2007

Bricker L, Neilson JP. Routine ultrasound in late pregnancy (after 24 weeks' gestation). Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD001451.pub2]

Bricker 2008

Bricker L, Neilson JP, Dowswell T. Routine ultrasound in late pregnancy (after 24 weeks' gestation). Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD001451.pub3]

Neilson 1995

Neilson JP. Routine fetal anthropometry in late pregnancy. [revised 12 May 1994]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C editor(s). Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software1995.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Alesund 1999

Methods

Randomisation by sealed envelopes.

Participants

Nearly all women in that geographical area, including those with 'high‐risk' pregnancies. Recruitment 1979‐1981. 1628 women.

Interventions

Routine ultrasound examination at 18 weeks (biparietal diameter measured) and 32 weeks (biparietal diameter and mean abdominal diameter) with additional examination at 36 weeks' gestation if fetus SGA and/or presenting by breech ‐ versus selective examination for clinical indications only.

Outcomes

Obstetric interventions (antepartum and intrapartum) for singleton pregnancies only. Perinatal outcome indices for all pregnancies (including multiple pregnancies).

Notes

This trial was reported in letter form only in 1984. It subsequently became clear that there were inconsistencies in results, and the data were subsequently re‐analysed. The data entered in this review are derived from more recent unpublished and published reports.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated.

Allocation concealment (selection bias)

Low risk

Described as "sealed envelope".

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

The data could be re‐included.

Selective reporting (reporting bias)

Low risk

Selective outcome reporting bias not apparent.

Other bias

High risk

More smokers in screened group; historical study.

Belanger 1996

Methods

Randomised controlled trial. Does not describe method of randomisation.

Participants

Total number of women randomised not stated. Follow‐up data for 286 singleton infants born to mothers.

Interventions

Intervention group: ultrasound at 16 to 20 weeks and 30 to 36 weeks, comparison group: scans only when clinically indicated.

Outcomes

Bayley evaluations – Mental Development Index (MDI) and Psychomotor Developmental (PDI).

Notes

Brief abstract, lacks full details for inclusions, data available not relevant.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Does not give sufficient detail; study described only as randomised.

Allocation concealment (selection bias)

Unclear risk

Allocation concealment is not described.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Does not give sufficient detail. Outcomes were collected at 6 and 18 months, with blinding not stated.

Incomplete outcome data (attrition bias)
All outcomes

High risk

Authors do not state the size of the full sample. Data here represent a subset.

Selective reporting (reporting bias)

Unclear risk

Data for 2 pre‐specified neurological development outcomes were collected for this subset of infants. It is unclear whether additional outcomes for the full sample were collected.

Other bias

Unclear risk

Bias assessment significantly compromised by lack of detail.

Belfast 2003

Methods

Randomised controlled trial. Randomisation by sealed, numbered envelopes.

Participants

Women recruited at 30 weeks' gestation assessed as low risk with singleton pregnancy and dates confirmed by 18‐20 weeks' anomaly scan.

Exclusion criteria: known medical or obstetric problems or known fetal anomaly.

1998 women recruited over a 21‐month period.

Interventions

Assessment 30 to 32 weeks and at 36 to 37 weeks by a midwife as part of routine care with midwife estimate of fetal size, presentation, position and amniotic fluid volume. In addition, the study group had ultrasound examinations by the specially trained midwife to assess liquor volume, fetal weight and placental maturity. The comparison group had selective ultrasound examinations if indicated.

Outcomes

SGA at birth, admission to special care and antenatal interventions.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated (restricted to achieve group balance).

Allocation concealment (selection bias)

Low risk

Sealed, numbered envelopes.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Good follow‐up for most outcomes.

Selective reporting (reporting bias)

Unclear risk

Difficult to interpret the results relating to the main outcome.

Other bias

Low risk

None detected.

Ellwood 1997

Methods

Randomised controlled trial.

Participants

Pregnant women < 20 weeks' gestation, recruited at booking visit to antenatal clinic. Women must have no pre‐existing medical conditions and in first ongoing pregnancy (1 first trimester loss allowed). 364 women recruited; interim report of data for 145 women.

Interventions

Intervention group: routine 18 to 20‐week scan, followed by uterine artery Doppler at 24 to 26 weeks; transvaginal assessment of cervix 24 to 26 weeks; growth and amniotic fluid index at 38 weeks. Comparison group: routine 18 to 20‐week scan and any others clinically indicated.

Outcomes

Gestation age at delivery, preterm delivery, unplanned admissions for pre‐eclampsia or intrauterine growth restriction and length of maternal stay, Apgar < 7 at 5 minutes, neonatal intensive care unit admissions and length of neonatal intensive care unit stay.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Sequence generation not described.

Allocation concealment (selection bias)

Low risk

Quote: "Randomisation carried out using the sealed envelope technique".

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

364 women recruited; interim report of data for 145 women. 2 women miscarried, 3 withdrew and 1 lost to follow‐up.

Selective reporting (reporting bias)

Low risk

Prespecified outcomes have been reported.

Other bias

Low risk

None detected.

Glasgow 1984

Methods

Pseudo‐randomisation according to last digit in hospital number.

Participants

877 women attending the hospital antenatal clinic between 34 to 36.5 weeks' gestation with uncomplicated singleton pregnancies, i.e. low‐risk pregnancies.

Interventions

All women had an ultrasound examination < 24 weeks' gestation for gestational dating. All had further ultrasound scan at 34 to 36.5 weeks' gestation to measure crown rump length and trunk area, but in the study group the 2 measurements were multiplied and the results plotted and reported in the case notes (i.e. revealed). Further management was the responsibility of the clinical staff. No requests for control group measurements to be revealed occurred, but this option was available to clinicians.

Outcomes

Obstetric interventions (antepartum and intrapartum) and perinatal outcome indices.

Notes

This study addressed ultrasound screening for small for dates.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

High risk

Described as allocated "from their hospital index numbers".

Allocation concealment (selection bias)

High risk

See above.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Small loss to follow‐up.

Selective reporting (reporting bias)

Low risk

Selective outcome reporting not detected.

Other bias

Unclear risk

There were more participants from social class V in the reported group.

New Zealand 1993

Methods

Randomised by women selecting 1 of a number of envelopes (< 6) containing a computer‐generated random 1 or 2 and a study number.

Participants

All pregnant women who attended antenatal clinic < 24 weeks' gestation, i.e. unselected population. Multiple pregnancies excluded once diagnosed (and study numbers reused). 1527 women.

Interventions

All women had a dating scan 16 to 24 weeks' gestation. Study group had a further scan at 32 to 36 weeks' gestation (ideally 34 weeks' gestation) that aimed to detect SGA fetuses, and if estimated fetal weight fell below the 20th centile for gestation, this was reported and additional scans recommended but not arranged. Clinicians were able to order further scans for the control group if clinically indicated.

Outcomes

Mainly perinatal outcome indices. Number of further ultrasound scans.

Notes

Scan to detect SGA.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Sequence computer‐generated.

Allocation concealment (selection bias)

Low risk

Randomised by women selecting 1 of a number of envelopes (< 6) containing a computer‐generated random 1 or 2 and a study number.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Not stated.

Selective reporting (reporting bias)

Unclear risk

No information provided.

Other bias

Unclear risk

No information provided.

Norway 1992

Methods

Combined findings from the Tronheim and Alesund trials for childhood developmental outcomes.

Participants

Alesund ‐ nearly all women in that geographical area, including those with 'high‐risk' pregnancies. Recruitment 1979‐1981. 1628 women.

Trondheim ‐ 1009 pregnant women in Trondheim attending for antenatal care between 1979‐1980.

Interventions

Alesund ‐ routine ultrasound examination at 18 weeks (biparietal diameter measured) and 32 weeks (biparietal diameter and mean abdominal diameter) with additional examination at 36 weeks' gestation if fetus SGA and/or presenting by breech ‐ versus selective examination for clinical indications only.

Trondheim ‐ study group offered ultrasound examinations at 19 weeks' and 32 weeks' gestation.

Outcomes

Follow‐up of singletons at 8 to 9 years including teacher assessed school performance, along with assessments of reading, speech and intelligence scores.

Notes

This is not strictly a separate study, but findings from the Alesund and Trondheim trials were combined for long‐term follow‐up.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated (both studies).

Allocation concealment (selection bias)

Low risk

Sealed envelopes.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not stated.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

2011 of 2824 eligible followed up.

Selective reporting (reporting bias)

Unclear risk

Outcome data collected are reported.

Other bias

Unclear risk

These data are for long‐term follow‐up.

Perth 1993

Methods

Sealed envelopes.

Participants

2834 singleton pregnancies. Criteria for recruitment were gestational age 16 to 20 weeks, sufficient proficiency in English, expected to deliver at the hospital and an intention to remain in Western Australia so that childhood follow‐up would be feasible.

Interventions

The 'regular' group had an ultrasound examination at 18 weeks for fetal biometry, subjective amniotic fluid assessment and placental morphology and location, and any further scans in pregnancy were conducted on clinicians request. The 'intensive group' had the aforementioned ultrasound examination, plus an amniotic fluid index and continuous wave Doppler ultrasound of the umbilical artery and an arcuate artery within the placental vascular bed at 18, 24, 28, 34 and 38 weeks' gestation. The Doppler ultrasound parameter reported was systolic/diastolic ratio. Results of these examinations were recorded in the hospital chart, but no clinical management guidance was given.

Outcomes

Obstetric interventions (antepartum and intrapartum) and perinatal outcome indices.

Notes

The published study reports the results overall, but little data are available for extraction. The authors were contacted and provided unpublished data.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Described as "computer‐generated random numbers".

Allocation concealment (selection bias)

Low risk

Described as "sealed envelopes".

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Some loss to follow‐up in both groups. "13 were lost to follow up in the intensive group of the trial and 20 in the regular" care group.

Selective reporting (reporting bias)

Low risk

Selective outcome reporting bias not detected.

Other bias

Low risk

Other bias not detected.

Peterborough 1987

Methods

Randomisation by opaque sealed envelopes.

Participants

2000 pregnant women attending the ultrasound department for routine third trimester scans, including multiple pregnancies.

Interventions

All women were offered routine early pregnancy ultrasound and 2 routine scans in the third trimester. Placental grading was performed at the routine third trimester scan. The results of placental grading in the study group were revealed, and the control group concealed. Clinical management in both groups was left entirely to the clinician responsible for care.

Outcomes

Obstetric interventions (antepartum and intrapartum) and perinatal outcome indices.

Notes

This study addresses the value of placental grading at routine third trimester ultrasound.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Described as "randomly allocated to 1 of 2 groups".

Allocation concealment (selection bias)

Low risk

Described as "a correspondingly numbered, sealed, opaque envelope".

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No losses to follow‐up.

Selective reporting (reporting bias)

Low risk

Selective outcome reporting not detected.

Other bias

Low risk

No other bias apparent.

RADIUS 1993

Methods

Randomisation by microcomputer after stratification by practice site. 109 participating practice sites recruited low‐risk women. Ultrasounds took place in 1 of 28 participating sites. Intention‐to‐treat.

Participants

15151 pregnant women who did not have "an indication for ultrasonography" based on uncertain gestational age, previous or index pregnancy complication, medical disorder. Therefore, those eligible were at low risk of adverse pregnancy outcome, and comprised 40% of the total population.

Interventions

Ultrasound screen at 18 to 20 weeks' and 31 to 33 weeks' gestation, versus selective ultrasonography only.

Outcomes

Perinatal outcome indices. The primary outcomes were perinatal mortality and moderate/severe neonatal morbidity.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Described as "computer‐generated randomisation sequence".

Allocation concealment (selection bias)

Low risk

Central randomisation performed after stratification by practice site.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

15,530 women recruited. Data for 15,151; 252 women (1.6%) lost to follow‐up and 127 women (0.8%) had spontaneous miscarriage. Reasons for loss similar for 2 groups.

Selective reporting (reporting bias)

Low risk

Selective outcome reporting bias not detected.

Other bias

Low risk

No other bias detected.

Skrastad 2013

Methods

Randomised controlled trial.

Participants

All pregnant women attending routine prenatal care living in 9 municipalities including and surrounding Trondheim, Norway. Data were collected between November 1989 and August 1992. The trial was not previously published "because the initial principal investigator left the department in the 1990s".

Interventions

Routine ultrasound at 18 and 33 weeks versus routine ultrasound at 18 weeks and on clinical indication only.

Outcomes

Detection rates of SGA and LGA babies, congenital anomalies, other adverse perinatal outcomes including caesarean section and ELCS, induction of labour, operative delivery, birthweight, perinatal death (stillbirth, neonatal death, perinatal death with no anomalies), Apgar < 7 at 5 minutes, meconium‐stained fluid, resuscitation, and admission to neonatal intensive care unit.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Sequence generation not described. Study described as randomised.

Allocation concealment (selection bias)

Low risk

Sealed envelope method used.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

42 women for whom estimated date of delivery was not available were excluded from the contributing data for the outcomes of SGA and LGA; these women were included in other outcomes. Study flowchart published with clear reasons for attrition. Loss to follow‐up 3.5% in study arm and 4.25% in control arm. Intention‐to‐treat analysis otherwise undertaken.

Selective reporting (reporting bias)

Low risk

Prespecified outcomes are reported.

Other bias

Low risk

None found.

Trondheim 1984

Methods

Randomised by sealed‐envelope method.

Participants

1009 pregnant women in Trondheim attending for antenatal care between 1979‐1980.

Interventions

Study group offered ultrasound examinations at 19 weeks' and 32 weeks' gestation.

Outcomes

Obstetric interventions (antepartum and intrapartum) and perinatal outcome indices.

Notes

Some data only presented for singletons (mean birthweight, birthweight < 10th centile, low birthweight, neonatal resuscitation, admission to special care, Apgar scores).

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated.

Allocation concealment (selection bias)

Low risk

Described as sealed envelopes.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Not feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Neonatal outcome assessment blinding ‐ yes.

Pregnancy outcome assessment blinding ‐ no.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Small loss to follow‐up.

Selective reporting (reporting bias)

Low risk

Selective outcome reporting bias not detected.

Other bias

Low risk

Other bias not apparent.

Wladimiroff 1980

Methods

Randomised by booking number (even numbers to group A, odd numbers to group B).

Participants

745 women enrolled during first antenatal care visit.

Interventions

Single fetal chest area measurement via ultrasound between 32 to 36 weeks versus no ultrasound.

Outcomes

Fetal chest area.

Notes

The primary aim of this study was to assess the ability of third trimester ultrasound in detecting small‐ and large‐for‐dates infants, and no clinical outcomes were evaluated.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

High risk

Randomised based on booking number.

Allocation concealment (selection bias)

High risk

All research staff would have known woman’s status based on hospital record number.

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Unfeasible.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Quote: ‘the medical staff were informed of the ultrasonic data obtained’ [where there were discrepancies in fundal height or any other abnormal antenatal finding].

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Small loss to follow‐up.

Selective reporting (reporting bias)

Low risk

Selective outcome reporting bias not detected.

Other bias

Low risk

None found.

ELCS: elective caesarean section
LGA: large‐for‐gestational age
SGA: small‐for‐gestational age

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Arzola 2013

Does not perform standard antenatal ultrasound, does not look at the effects of having an ultrasound > 24 weeks or not. This trial was simply trying to generate a model to predict gastric volume in non‐fasted women based on ultrasound; outcome data not stated clearly but unlikely to be relevant.

Hendrix 2000

Compared clinical versus ultrasound estimates of birthweight in terms of accuracy. Did not include review outcomes.

Morrison 1992

Brief abstract. No usable data. Unclear whether this trial was completed.

Ong 2001

Study not undertaken.

Owen 1994

Brief abstract. No usable data. Unclear if non‐randomised women were included in the analysis. Women also considered to be 'at risk' rather than unselected or low risk.

Secher 1986

The methodology is unclear as all suspected LGA fetuses were to be referred to an obstetrician for further evaluation. However, suspected LGA in 26 such fetuses included in the final analysis was not reported to clinicians primarily because they were part of another randomised study. The other randomised trial (Secher 1987) was also not included ‐ see reasons in this table.

Secher 1987

In this study, third trimester ultrasound was used to identify a group of uncomplicated pregnancies where there was ultrasound suspicion of poor intrauterine growth, but no clinical suspicion of poor growth. Only these pregnancies were randomised. The revealed group underwent serial tests of fetal well being (non‐stress CTG and serum oestriol and placental lactogen) and fetal growth and management was planned depending on the results of the tests. Therefore, the study assessed the value of various tests of fetal well being if fetal growth retardation was suspected, rather than the value of routine third trimester ultrasound alone.

CTG: cardiotocograph
LGA: large‐for‐gestational age

Characteristics of ongoing studies [ordered by study ID]

McClure 2014

Trial name or title

First Look: a cluster‐randomised trial of ultrasound to improve pregnancy outcomes in low‐income country settings.

Methods

Randomised controlled trial, ongoing.

Participants

All pregnant women presenting for routine antenatal care, ≥ 18 weeks and not in labour.

Interventions

Antenatal routine ultrasound 18‐22 weeks' gestation and 32‐36 weeks' gestation versus routine antenatal care.

Outcomes

Maternal and fetal mortality and morbidity, healthcare utilisation.

Starting date

Protocol publication: 5 February 2014.

Contact information

Elizabeth McClure [email protected]

Notes

Verspyck 2012

Trial name or title

RECRET: Routine ultrasound screening in the third trimester.

Methods

Randomised controlled trial, ongoing.

Participants

Pregnant women at low‐risk of complications, singleton only.

Interventions

Ultrasound between 34‐35 weeks versus ultrasound between 30‐31 weeks.

Outcomes

Small‐for‐gestational age, intrauterine growth restriction, healthcare utilisation outcomes, maternal and neonatal outcomes.

Starting date

May 2012.

Contact information

Eric Verspyck eric.verspyck@chu‐rouen.fr

Notes

Data and analyses

Open in table viewer
Comparison 1. Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Induction of labour Show forest plot

6

22663

Risk Ratio (M‐H, Random, 95% CI)

0.93 [0.81, 1.07]

Analysis 1.1

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 1 Induction of labour.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 1 Induction of labour.

2 Caesarean section Show forest plot

6

27461

Risk Ratio (M‐H, Random, 95% CI)

1.03 [0.92, 1.15]

Analysis 1.2

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 2 Caesarean section.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 2 Caesarean section.

3 Perinatal mortality Show forest plot

8

30675

Risk Ratio (M‐H, Random, 95% CI)

1.01 [0.67, 1.54]

Analysis 1.3

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 3 Perinatal mortality.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 3 Perinatal mortality.

4 Preterm delivery < 37 weeks' gestation Show forest plot

2

17151

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.85, 1.08]

Analysis 1.4

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 4 Preterm delivery < 37 weeks' gestation.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 4 Preterm delivery < 37 weeks' gestation.

5 Antenatal admission Show forest plot

4

5396

Risk Ratio (M‐H, Random, 95% CI)

1.07 [0.80, 1.43]

Analysis 1.5

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 5 Antenatal admission.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 5 Antenatal admission.

6 Number of days in hospital (mean, standard deviation (SD)) (non‐prespecified) Show forest plot

1

877

Mean Difference (IV, Fixed, 95% CI)

0.10 [0.07, 0.13]

Analysis 1.6

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 6 Number of days in hospital (mean, standard deviation (SD)) (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 6 Number of days in hospital (mean, standard deviation (SD)) (non‐prespecified).

7 CTG (cardiotocograph) Show forest plot

1

2000

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.97, 1.06]

Analysis 1.7

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 7 CTG (cardiotocograph).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 7 CTG (cardiotocograph).

8 Further ultrasound scan/s Show forest plot

2

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

Analysis 1.8

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 8 Further ultrasound scan/s.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 8 Further ultrasound scan/s.

9 Instrumental delivery Show forest plot

5

12310

Risk Ratio (M‐H, Fixed, 95% CI)

1.05 [0.95, 1.16]

Analysis 1.9

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 9 Instrumental delivery.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 9 Instrumental delivery.

10 Elective caesarean section Show forest plot

4

5884

Risk Ratio (M‐H, Fixed, 95% CI)

1.09 [0.89, 1.34]

Analysis 1.10

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 10 Elective caesarean section.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 10 Elective caesarean section.

11 Emergency caesarean section Show forest plot

5

12310

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.89, 1.20]

Analysis 1.11

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 11 Emergency caesarean section.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 11 Emergency caesarean section.

12 Gestation at birth (mean, SD) Show forest plot

3

9303

Mean Difference (IV, Random, 95% CI)

‐0.10 [‐0.22, 0.02]

Analysis 1.12

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 12 Gestation at birth (mean, SD).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 12 Gestation at birth (mean, SD).

13 Birthweight (mean, SD) Show forest plot

5

26136

Mean Difference (IV, Fixed, 95% CI)

4.40 [‐8.89, 17.69]

Analysis 1.13

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 13 Birthweight (mean, SD).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 13 Birthweight (mean, SD).

14 Birthweight < 10th centile Show forest plot

4

20293

Risk Ratio (M‐H, Random, 95% CI)

0.98 [0.74, 1.28]

Analysis 1.14

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 14 Birthweight < 10th centile.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 14 Birthweight < 10th centile.

15 Low birthweight < 2.5 kg Show forest plot

3

4510

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.71, 1.18]

Analysis 1.15

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 15 Low birthweight < 2.5 kg.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 15 Low birthweight < 2.5 kg.

16 Neonatal resuscitation Show forest plot

5

12909

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.84, 1.08]

Analysis 1.16

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 16 Neonatal resuscitation.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 16 Neonatal resuscitation.

17 Neonatal ventilation Show forest plot

2

3004

Risk Ratio (M‐H, Random, 95% CI)

0.64 [0.23, 1.77]

Analysis 1.17

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 17 Neonatal ventilation.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 17 Neonatal ventilation.

18 Admission to special care baby unit Show forest plot

5

12915

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.91, 1.14]

Analysis 1.18

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 18 Admission to special care baby unit.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 18 Admission to special care baby unit.

19 Apgar score < 7 at 5 minutes Show forest plot

4

5889

Risk Ratio (M‐H, Random, 95% CI)

0.89 [0.41, 1.93]

Analysis 1.19

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 19 Apgar score < 7 at 5 minutes.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 19 Apgar score < 7 at 5 minutes.

20 Stillbirths (non‐prespecified) Show forest plot

6

28107

Risk Ratio (M‐H, Random, 95% CI)

1.18 [0.51, 2.70]

Analysis 1.20

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 20 Stillbirths (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 20 Stillbirths (non‐prespecified).

21 Neonatal deaths Show forest plot

5

21708

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.58, 1.85]

Analysis 1.21

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 21 Neonatal deaths.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 21 Neonatal deaths.

22 Perinatal mortality (excluding congenital abnormalities) (non‐prespecified) Show forest plot

6

28133

Risk Ratio (M‐H, Random, 95% CI)

1.13 [0.58, 2.19]

Analysis 1.22

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 22 Perinatal mortality (excluding congenital abnormalities) (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 22 Perinatal mortality (excluding congenital abnormalities) (non‐prespecified).

23 Stillbirths (excluding congenital abnormalities) (non‐prespecified) Show forest plot

2

2902

Risk Ratio (M‐H, Fixed, 95% CI)

0.05 [0.00, 0.90]

Analysis 1.23

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 23 Stillbirths (excluding congenital abnormalities) (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 23 Stillbirths (excluding congenital abnormalities) (non‐prespecified).

24 Neonatal deaths (excluding congenital abnormalities) Show forest plot

2

2902

Risk Ratio (M‐H, Fixed, 95% CI)

1.99 [0.18, 21.96]

Analysis 1.24

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 24 Neonatal deaths (excluding congenital abnormalities).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 24 Neonatal deaths (excluding congenital abnormalities).

25 Post‐term delivery > 42 weeks' gestation (non‐prespecified) Show forest plot

2

17151

Risk Ratio (M‐H, Fixed, 95% CI)

0.69 [0.59, 0.81]

Analysis 1.25

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 25 Post‐term delivery > 42 weeks' gestation (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 25 Post‐term delivery > 42 weeks' gestation (non‐prespecified).

26 Birthweight < 5th centile (non‐prespecified) Show forest plot

2

2404

Risk Ratio (M‐H, Fixed, 95% CI)

1.18 [0.81, 1.74]

Analysis 1.26

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 26 Birthweight < 5th centile (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 26 Birthweight < 5th centile (non‐prespecified).

27 Moderate neonatal morbidity (non‐prespecified) Show forest plot

1

15281

Risk Ratio (M‐H, Fixed, 95% CI)

0.97 [0.81, 1.16]

Analysis 1.27

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 27 Moderate neonatal morbidity (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 27 Moderate neonatal morbidity (non‐prespecified).

28 Severe neonatal morbidity (non‐prespecified) Show forest plot

1

15281

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.78, 1.36]

Analysis 1.28

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 28 Severe neonatal morbidity (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 28 Severe neonatal morbidity (non‐prespecified).

29 Perinatal mortality (twins) (non‐prespecified) Show forest plot

3

314

Risk Ratio (M‐H, Fixed, 95% CI)

0.63 [0.24, 1.66]

Analysis 1.29

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 29 Perinatal mortality (twins) (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 29 Perinatal mortality (twins) (non‐prespecified).

Open in table viewer
Comparison 2. Serial ultrasound and Doppler ultrasound versus selective ultrasound

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Induction of labour Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.92, 1.14]

Analysis 2.1

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 1 Induction of labour.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 1 Induction of labour.

2 Caesarean section Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.76, 1.03]

Analysis 2.2

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 2 Caesarean section.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 2 Caesarean section.

3 Perinatal mortality Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.59 [0.30, 1.17]

Analysis 2.3

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 3 Perinatal mortality.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 3 Perinatal mortality.

4 CTG (cardiograph) Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.93, 1.09]

Analysis 2.4

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 4 CTG (cardiograph).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 4 CTG (cardiograph).

5 Elective caesarean section Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.77, 1.17]

Analysis 2.5

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 5 Elective caesarean section.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 5 Elective caesarean section.

6 Emergency caesarean section Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.82 [0.64, 1.05]

Analysis 2.6

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 6 Emergency caesarean section.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 6 Emergency caesarean section.

7 Gestation at birth (mean, SD) Show forest plot

1

2834

Mean Difference (IV, Fixed, 95% CI)

‐0.10 [‐1.21, 1.01]

Analysis 2.7

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 7 Gestation at birth (mean, SD).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 7 Gestation at birth (mean, SD).

8 Birthweight (mean, SD) Show forest plot

1

2834

Mean Difference (IV, Fixed, 95% CI)

‐25.0 [‐67.53, 17.53]

Analysis 2.8

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 8 Birthweight (mean, SD).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 8 Birthweight (mean, SD).

9 Birthweight < 10th centile Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.36 [1.10, 1.68]

Analysis 2.9

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 9 Birthweight < 10th centile.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 9 Birthweight < 10th centile.

10 Birthweight < 3rd centile Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.66 [1.10, 2.51]

Analysis 2.10

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 10 Birthweight < 3rd centile.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 10 Birthweight < 3rd centile.

11 Low birthweight (< 2.5 kg) Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.14 [0.85, 1.52]

Analysis 2.11

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 11 Low birthweight (< 2.5 kg).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 11 Low birthweight (< 2.5 kg).

12 Very low birthweight (< 1.5 kg) Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.27 [0.65, 2.49]

Analysis 2.12

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 12 Very low birthweight (< 1.5 kg).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 12 Very low birthweight (< 1.5 kg).

13 Need for resuscitation Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.92, 1.05]

Analysis 2.13

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 13 Need for resuscitation.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 13 Need for resuscitation.

14 Need for ventilation Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.67 [0.41, 1.09]

Analysis 2.14

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 14 Need for ventilation.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 14 Need for ventilation.

15 Admission to special care baby unit Show forest plot

2

2979

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.69, 1.30]

Analysis 2.15

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 15 Admission to special care baby unit.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 15 Admission to special care baby unit.

16 Apgar score < 7 at 5 minutes Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.77 [0.46, 1.27]

Analysis 2.16

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 16 Apgar score < 7 at 5 minutes.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 16 Apgar score < 7 at 5 minutes.

17 Neonatal intraventricular haemorrhage Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.80 [0.22, 2.98]

Analysis 2.17

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 17 Neonatal intraventricular haemorrhage.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 17 Neonatal intraventricular haemorrhage.

18 Stillbirths Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.36, 1.93]

Analysis 2.18

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 18 Stillbirths.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 18 Stillbirths.

19 Neonatal deaths (non‐prespecified) Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.30 [0.08, 1.09]

Analysis 2.19

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 19 Neonatal deaths (non‐prespecified).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 19 Neonatal deaths (non‐prespecified).

20 Neonatal deaths (excluding congenital abnormalities) (non‐prespecified) Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.40 [0.08, 2.06]

Analysis 2.20

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 20 Neonatal deaths (excluding congenital abnormalities) (non‐prespecified).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 20 Neonatal deaths (excluding congenital abnormalities) (non‐prespecified).

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 1

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 2

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 1 Induction of labour.
Figuras y tablas -
Analysis 1.1

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 1 Induction of labour.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 2 Caesarean section.
Figuras y tablas -
Analysis 1.2

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 2 Caesarean section.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 3 Perinatal mortality.
Figuras y tablas -
Analysis 1.3

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 3 Perinatal mortality.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 4 Preterm delivery < 37 weeks' gestation.
Figuras y tablas -
Analysis 1.4

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 4 Preterm delivery < 37 weeks' gestation.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 5 Antenatal admission.
Figuras y tablas -
Analysis 1.5

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 5 Antenatal admission.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 6 Number of days in hospital (mean, standard deviation (SD)) (non‐prespecified).
Figuras y tablas -
Analysis 1.6

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 6 Number of days in hospital (mean, standard deviation (SD)) (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 7 CTG (cardiotocograph).
Figuras y tablas -
Analysis 1.7

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 7 CTG (cardiotocograph).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 8 Further ultrasound scan/s.
Figuras y tablas -
Analysis 1.8

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 8 Further ultrasound scan/s.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 9 Instrumental delivery.
Figuras y tablas -
Analysis 1.9

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 9 Instrumental delivery.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 10 Elective caesarean section.
Figuras y tablas -
Analysis 1.10

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 10 Elective caesarean section.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 11 Emergency caesarean section.
Figuras y tablas -
Analysis 1.11

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 11 Emergency caesarean section.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 12 Gestation at birth (mean, SD).
Figuras y tablas -
Analysis 1.12

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 12 Gestation at birth (mean, SD).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 13 Birthweight (mean, SD).
Figuras y tablas -
Analysis 1.13

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 13 Birthweight (mean, SD).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 14 Birthweight < 10th centile.
Figuras y tablas -
Analysis 1.14

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 14 Birthweight < 10th centile.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 15 Low birthweight < 2.5 kg.
Figuras y tablas -
Analysis 1.15

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 15 Low birthweight < 2.5 kg.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 16 Neonatal resuscitation.
Figuras y tablas -
Analysis 1.16

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 16 Neonatal resuscitation.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 17 Neonatal ventilation.
Figuras y tablas -
Analysis 1.17

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 17 Neonatal ventilation.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 18 Admission to special care baby unit.
Figuras y tablas -
Analysis 1.18

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 18 Admission to special care baby unit.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 19 Apgar score < 7 at 5 minutes.
Figuras y tablas -
Analysis 1.19

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 19 Apgar score < 7 at 5 minutes.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 20 Stillbirths (non‐prespecified).
Figuras y tablas -
Analysis 1.20

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 20 Stillbirths (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 21 Neonatal deaths.
Figuras y tablas -
Analysis 1.21

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 21 Neonatal deaths.

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 22 Perinatal mortality (excluding congenital abnormalities) (non‐prespecified).
Figuras y tablas -
Analysis 1.22

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 22 Perinatal mortality (excluding congenital abnormalities) (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 23 Stillbirths (excluding congenital abnormalities) (non‐prespecified).
Figuras y tablas -
Analysis 1.23

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 23 Stillbirths (excluding congenital abnormalities) (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 24 Neonatal deaths (excluding congenital abnormalities).
Figuras y tablas -
Analysis 1.24

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 24 Neonatal deaths (excluding congenital abnormalities).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 25 Post‐term delivery > 42 weeks' gestation (non‐prespecified).
Figuras y tablas -
Analysis 1.25

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 25 Post‐term delivery > 42 weeks' gestation (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 26 Birthweight < 5th centile (non‐prespecified).
Figuras y tablas -
Analysis 1.26

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 26 Birthweight < 5th centile (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 27 Moderate neonatal morbidity (non‐prespecified).
Figuras y tablas -
Analysis 1.27

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 27 Moderate neonatal morbidity (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 28 Severe neonatal morbidity (non‐prespecified).
Figuras y tablas -
Analysis 1.28

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 28 Severe neonatal morbidity (non‐prespecified).

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 29 Perinatal mortality (twins) (non‐prespecified).
Figuras y tablas -
Analysis 1.29

Comparison 1 Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks, Outcome 29 Perinatal mortality (twins) (non‐prespecified).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 1 Induction of labour.
Figuras y tablas -
Analysis 2.1

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 1 Induction of labour.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 2 Caesarean section.
Figuras y tablas -
Analysis 2.2

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 2 Caesarean section.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 3 Perinatal mortality.
Figuras y tablas -
Analysis 2.3

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 3 Perinatal mortality.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 4 CTG (cardiograph).
Figuras y tablas -
Analysis 2.4

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 4 CTG (cardiograph).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 5 Elective caesarean section.
Figuras y tablas -
Analysis 2.5

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 5 Elective caesarean section.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 6 Emergency caesarean section.
Figuras y tablas -
Analysis 2.6

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 6 Emergency caesarean section.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 7 Gestation at birth (mean, SD).
Figuras y tablas -
Analysis 2.7

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 7 Gestation at birth (mean, SD).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 8 Birthweight (mean, SD).
Figuras y tablas -
Analysis 2.8

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 8 Birthweight (mean, SD).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 9 Birthweight < 10th centile.
Figuras y tablas -
Analysis 2.9

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 9 Birthweight < 10th centile.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 10 Birthweight < 3rd centile.
Figuras y tablas -
Analysis 2.10

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 10 Birthweight < 3rd centile.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 11 Low birthweight (< 2.5 kg).
Figuras y tablas -
Analysis 2.11

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 11 Low birthweight (< 2.5 kg).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 12 Very low birthweight (< 1.5 kg).
Figuras y tablas -
Analysis 2.12

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 12 Very low birthweight (< 1.5 kg).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 13 Need for resuscitation.
Figuras y tablas -
Analysis 2.13

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 13 Need for resuscitation.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 14 Need for ventilation.
Figuras y tablas -
Analysis 2.14

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 14 Need for ventilation.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 15 Admission to special care baby unit.
Figuras y tablas -
Analysis 2.15

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 15 Admission to special care baby unit.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 16 Apgar score < 7 at 5 minutes.
Figuras y tablas -
Analysis 2.16

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 16 Apgar score < 7 at 5 minutes.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 17 Neonatal intraventricular haemorrhage.
Figuras y tablas -
Analysis 2.17

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 17 Neonatal intraventricular haemorrhage.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 18 Stillbirths.
Figuras y tablas -
Analysis 2.18

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 18 Stillbirths.

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 19 Neonatal deaths (non‐prespecified).
Figuras y tablas -
Analysis 2.19

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 19 Neonatal deaths (non‐prespecified).

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 20 Neonatal deaths (excluding congenital abnormalities) (non‐prespecified).
Figuras y tablas -
Analysis 2.20

Comparison 2 Serial ultrasound and Doppler ultrasound versus selective ultrasound, Outcome 20 Neonatal deaths (excluding congenital abnormalities) (non‐prespecified).

Summary of findings for the main comparison. Routine ultrasound > 24 weeks for pregnant women

Routine ultrasound > 24 weeks for pregnant women

Patient or population: women in late pregnancy (after 24 weeks' gestation) in both unselected populations and designated low‐risk populations
Settings: Scandinavia, Northern Ireland, New Zealand, Australia and the United Kingdom
Intervention: routine ultrasound > 24 weeks versus no/concealed/selective ultrasound

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Routine ultrasound > 24 weeks

Perinatal mortality

Study population

RR 1.01
(0.67 to 1.54)

30675
(8 studies)

⊕⊕⊕⊝
moderate1

6 per 1000

6 per 1000
(4 to 9)

Moderate

5 per 1000

5 per 1000
(3 to 8)

Preterm delivery < 37 weeks' gestation

Study population

RR 0.96
(0.85 to 1.08)

17151
(2 studies)

⊕⊕⊕⊕
high

59 per 1000

57 per 1000
(50 to 64)

Moderate

60 per 1000

58 per 1000
(51 to 65)

Induction of labour

Study population

RR 0.93
(0.81 to 1.07)

22663
(6 studies)

⊕⊕⊕⊝
moderate2

238 per 1000

222 per 1000
(193 to 255)

Moderate

242 per 1000

225 per 1000
(196 to 259)

Caesarean section

Study population

RR 1.02
(0.97 to 1.09)

27461
(6 studies)

⊕⊕⊕⊕
high

139 per 1000

142 per 1000
(135 to 152)

Moderate

133 per 1000

136 per 1000
(129 to 145)

Preterm delivery less than 34 weeks

Study population

Not estimable

0
(0)

Not estimable

None of the included trials in this review collected data for this outcome.

See comment

Maternal psychological effects

Study population

Not estimable

0
(0)

Not estimable

None of the included trials in this review collected data for this outcome.

See comment

Neurodevelopment at age 2

Study population

Not estimable

0
(0)

Not estimable

None of the included trials in this review collected data for this outcome.

See comment

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Wide confidence interval crossing the line of no effect. RR 1.01 (0.67 to 1.54)
2 Statistical heterogeneity I² = 78%

Figuras y tablas -
Summary of findings for the main comparison. Routine ultrasound > 24 weeks for pregnant women
Comparison 1. Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Induction of labour Show forest plot

6

22663

Risk Ratio (M‐H, Random, 95% CI)

0.93 [0.81, 1.07]

2 Caesarean section Show forest plot

6

27461

Risk Ratio (M‐H, Random, 95% CI)

1.03 [0.92, 1.15]

3 Perinatal mortality Show forest plot

8

30675

Risk Ratio (M‐H, Random, 95% CI)

1.01 [0.67, 1.54]

4 Preterm delivery < 37 weeks' gestation Show forest plot

2

17151

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.85, 1.08]

5 Antenatal admission Show forest plot

4

5396

Risk Ratio (M‐H, Random, 95% CI)

1.07 [0.80, 1.43]

6 Number of days in hospital (mean, standard deviation (SD)) (non‐prespecified) Show forest plot

1

877

Mean Difference (IV, Fixed, 95% CI)

0.10 [0.07, 0.13]

7 CTG (cardiotocograph) Show forest plot

1

2000

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.97, 1.06]

8 Further ultrasound scan/s Show forest plot

2

Risk Ratio (M‐H, Random, 95% CI)

Totals not selected

9 Instrumental delivery Show forest plot

5

12310

Risk Ratio (M‐H, Fixed, 95% CI)

1.05 [0.95, 1.16]

10 Elective caesarean section Show forest plot

4

5884

Risk Ratio (M‐H, Fixed, 95% CI)

1.09 [0.89, 1.34]

11 Emergency caesarean section Show forest plot

5

12310

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.89, 1.20]

12 Gestation at birth (mean, SD) Show forest plot

3

9303

Mean Difference (IV, Random, 95% CI)

‐0.10 [‐0.22, 0.02]

13 Birthweight (mean, SD) Show forest plot

5

26136

Mean Difference (IV, Fixed, 95% CI)

4.40 [‐8.89, 17.69]

14 Birthweight < 10th centile Show forest plot

4

20293

Risk Ratio (M‐H, Random, 95% CI)

0.98 [0.74, 1.28]

15 Low birthweight < 2.5 kg Show forest plot

3

4510

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.71, 1.18]

16 Neonatal resuscitation Show forest plot

5

12909

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.84, 1.08]

17 Neonatal ventilation Show forest plot

2

3004

Risk Ratio (M‐H, Random, 95% CI)

0.64 [0.23, 1.77]

18 Admission to special care baby unit Show forest plot

5

12915

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.91, 1.14]

19 Apgar score < 7 at 5 minutes Show forest plot

4

5889

Risk Ratio (M‐H, Random, 95% CI)

0.89 [0.41, 1.93]

20 Stillbirths (non‐prespecified) Show forest plot

6

28107

Risk Ratio (M‐H, Random, 95% CI)

1.18 [0.51, 2.70]

21 Neonatal deaths Show forest plot

5

21708

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.58, 1.85]

22 Perinatal mortality (excluding congenital abnormalities) (non‐prespecified) Show forest plot

6

28133

Risk Ratio (M‐H, Random, 95% CI)

1.13 [0.58, 2.19]

23 Stillbirths (excluding congenital abnormalities) (non‐prespecified) Show forest plot

2

2902

Risk Ratio (M‐H, Fixed, 95% CI)

0.05 [0.00, 0.90]

24 Neonatal deaths (excluding congenital abnormalities) Show forest plot

2

2902

Risk Ratio (M‐H, Fixed, 95% CI)

1.99 [0.18, 21.96]

25 Post‐term delivery > 42 weeks' gestation (non‐prespecified) Show forest plot

2

17151

Risk Ratio (M‐H, Fixed, 95% CI)

0.69 [0.59, 0.81]

26 Birthweight < 5th centile (non‐prespecified) Show forest plot

2

2404

Risk Ratio (M‐H, Fixed, 95% CI)

1.18 [0.81, 1.74]

27 Moderate neonatal morbidity (non‐prespecified) Show forest plot

1

15281

Risk Ratio (M‐H, Fixed, 95% CI)

0.97 [0.81, 1.16]

28 Severe neonatal morbidity (non‐prespecified) Show forest plot

1

15281

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.78, 1.36]

29 Perinatal mortality (twins) (non‐prespecified) Show forest plot

3

314

Risk Ratio (M‐H, Fixed, 95% CI)

0.63 [0.24, 1.66]

Figuras y tablas -
Comparison 1. Routine ultrasound > 24 weeks versus no/concealed/selective ultrasound > 24 weeks
Comparison 2. Serial ultrasound and Doppler ultrasound versus selective ultrasound

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Induction of labour Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.92, 1.14]

2 Caesarean section Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.76, 1.03]

3 Perinatal mortality Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.59 [0.30, 1.17]

4 CTG (cardiograph) Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.93, 1.09]

5 Elective caesarean section Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.77, 1.17]

6 Emergency caesarean section Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.82 [0.64, 1.05]

7 Gestation at birth (mean, SD) Show forest plot

1

2834

Mean Difference (IV, Fixed, 95% CI)

‐0.10 [‐1.21, 1.01]

8 Birthweight (mean, SD) Show forest plot

1

2834

Mean Difference (IV, Fixed, 95% CI)

‐25.0 [‐67.53, 17.53]

9 Birthweight < 10th centile Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.36 [1.10, 1.68]

10 Birthweight < 3rd centile Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.66 [1.10, 2.51]

11 Low birthweight (< 2.5 kg) Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.14 [0.85, 1.52]

12 Very low birthweight (< 1.5 kg) Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

1.27 [0.65, 2.49]

13 Need for resuscitation Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.92, 1.05]

14 Need for ventilation Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.67 [0.41, 1.09]

15 Admission to special care baby unit Show forest plot

2

2979

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.69, 1.30]

16 Apgar score < 7 at 5 minutes Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.77 [0.46, 1.27]

17 Neonatal intraventricular haemorrhage Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.80 [0.22, 2.98]

18 Stillbirths Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.36, 1.93]

19 Neonatal deaths (non‐prespecified) Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.30 [0.08, 1.09]

20 Neonatal deaths (excluding congenital abnormalities) (non‐prespecified) Show forest plot

1

2834

Risk Ratio (M‐H, Fixed, 95% CI)

0.40 [0.08, 2.06]

Figuras y tablas -
Comparison 2. Serial ultrasound and Doppler ultrasound versus selective ultrasound